Chemical Biology Conference

Date: September 30th, 2026

Host: Jnana and GSK

Location: The Broad Institute, Cambridge MA

Chemical Biology in the HUB logoAbout the Conference

The science will focus cutting edge research in Chemical Biology from both academic and industry labs in the areas of machine learning applied to drug discovery, translational chemical biology, targeted protein degradation, chemical proteomics, novel target identification/validation, forward thinking synthetic strategies for chemical biology and chemical imaging.

The symposium will be followed by a reception with appetizers and refreshments for the symposium speakers and attendees. We anticipate that there will be approximately 240 attendees. Our target audience is a diverse mix of chemical biologists, including students and professionals from industry and academia.

2026 tickets will be available in two waves (labeled: day 1 and day 2 – just denoting the day they go on sale). Wednesday, August 12 at noon and Thursday, August 13 at 5 pm. You may join the waitlist after the day 1 tickets sell out, but you should try to purchase in the second wave. If tickets are sold out after the second wave, you will find the waitlist under Day 1.

2026 Speakers

2026 Agenda

8:15 – 9:00 am            Registration and coffee

9:00 – 9:05 am            Opening remarks

9:05 – 9:35 am            Logan Combee, GSK

Employing DNA-encoded Libraries for Molecular Glue Discovery

9:35 – 10:15 am          Katherine Donovan, DFCI/Broad Institute

Unveiling the hidden interactome of CRBN molecular glues

10:15 – 10:25 am        Flash Talk

10:25 – 10:45 am        Coffee Break

10:45 – 11:15 am        Robert Everley, Frontier

Understanding in vivo target occupancy relationships: insights from target vulnerability and turnover

11:15 – 11:55 am        Jacob Geri, Weill Cornell

Spatial protein interactomics and proteome-wide biophysics with high resolution proximity labeling

11:55 – 12:05 pm       Flash Talk

12:10 pm – 1:00 pm   Lunch

1:00 – 1:40 pm            Xiao Wang, MIT/Broad

Deconstruct and reprogram the RNA lifecycle

1:40 – 2:10 pm            Mary Matyskiela, Neomorph

Pushing the boundaries of molecular glue therapeutics from discovery to the clinic. 

2:10 – 2:50 pm            John Schneekloth, NCI/U Michigan

Structure and Screening Based Approaches to Reveal Serendipitous Pharmacology from RNA-binding Molecules

2:50 – 3:00 pm                Flash Talk

3:00 – 3:20 pm            Coffee break

3:20 – 4:00 pm            Chris Parker, Scripps

Expanding the Chemical Tractability of the Human Proteome

4:00 – 4:35 pm            Steve Canham, Novartis

Phenotypic profiling by cell painting leads to identification of novel translation inhibitors

4:35 – 4:40 pm            Closing remarks

4:40 – 6:30 pm            Poster session and reception

Key Topics

Machine Learning

Translational Chemical Biology

Targeted Protein Degradation

Target Identification

Chemical Imaging

8:15 – 9:00 am            Registration and coffee

9:00 – 9:05 am            Opening remarks

9:05 – 9:35 am            Logan Combee, GSK

Employing DNA-encoded Libraries for Molecular Glue Discovery

9:35 – 10:15 am          Katherine Donovan, DFCI/Broad Institute

Unveiling the hidden interactome of CRBN molecular glues

10:15 – 10:25 am        Flash Talk

10:25 – 10:45 am        Coffee Break

10:45 – 11:15 am        Robert Everley, Frontier

Understanding in vivo target occupancy relationships: insights from target vulnerability and turnover

11:15 – 11:55 am        Jacob Geri, Weill Cornell

Spatial protein interactomics and proteome-wide biophysics with high resolution proximity labeling

11:55 – 12:05 pm       Flash Talk

12:10 pm – 1:00 pm   Lunch

1:00 – 1:40 pm            Xiao Wang, MIT/Broad

Deconstruct and reprogram the RNA lifecycle

1:40 – 2:10 pm            Mary Matyskiela, Neomorph

Pushing the boundaries of molecular glue therapeutics from discovery to the clinic. 

2:10 – 2:50 pm            John Schneekloth, NCI/U Michigan

Structure and Screening Based Approaches to Reveal Serendipitous Pharmacology from RNA-binding Molecules

2:50 – 3:00 pm                Flash Talk

3:00 – 3:20 pm            Coffee break

3:20 – 4:00 pm            Chris Parker, Scripps

Expanding the Chemical Tractability of the Human Proteome

4:00 – 4:35 pm            Steve Canham, Novartis

Phenotypic profiling by cell painting leads to identification of novel translation inhibitors

4:35 – 4:40 pm            Closing remarks

4:40 – 6:30 pm            Poster session and reception

Parking information

The Broad is located in the heart of Kendall Square and is walking distance from the Kendall Square T-stop of the Red Line. There are also numerous parking garages in the area.

For driving directions from where you will begin your trip, enter “415 Main St, Cambridge, MA 02142”

Lactation rooms are available but require reservation. Please reach out to Erin Hickey at: hickeyer@broadinstitute.org

2025

Host: Bristol Myer Squibb

  • Ziyang Zhang, UC Berkeley
  • Fleur Ferguson, UCSF
  • Bradley Pentelute, MIT
  • Liron Bar-Peled, MGH
  • Cigall Kadoch, DFCI, Broad
  • Dennis Hu, DrugHunter
  • Leon Murphy, Casma
  • Angela Cacace, Arvinas
  • Emily Cherney, Bristol Myer Squibb

2024

Host: Novartis

  • Christine Mayr, Sloan Kettering Institute
  • Raymond Moellering, University of Chicago
  • Jonathan Ostrem, UCSF
  • Bridget Wagner, Arena Bioworks
  • Jim Wells, UCSF
  • Xiaoqing Han and Serene Keilani, Merck
  • Wankyu Lee, AstraZeneca
  • Jaimeen Devraj Majmudar, Pfizer
  • Jeff Martin, Biogen
  • Jonathan Solomon, Novartis

2023

Host: Vertex

  • Michelle Arkin, UCSF
  • Keriann Backus, UCLA
  • Ed Couchani, Harvard University Dana-Farber Cancer Institute
  • Justin Kim, Harvard University Dana-Farber Cancer Institute
  • Dannete Daniels, Foghorn Therapeutics
  • Jonathan Hurov, FogPharma
  • Heather Murrey, Scorpion Therapeutics
  • Justin Rettenmaier & Matt Labenski, Jnana Therapeutics
  • Ben Ruprecht, Covant Therapeutics

2022

Host: Pfizer

  • Steve Gygi, Harvard Medical School
  • Laura Kiessling, MIT
  • Brian Liau, Harvard University
  • Paul Thompson, Umass Worcester
  • Christina Woo, Harvard University
  • Derek Lowe, Novartis
  • Kirti Sharma, Kymera Therapeutics
  • Monica Schenone, Pfizer
  • Fireside chat: Dafydd Owen, Bruce Booth, Nello Mainolfi

2019

Host: Merck

  • Regina Barzilay, MIT
  • Carolyn Bertozzi, Stanford University
  • Angela Kohler, MIT
  • Milka Kostic, Harvard University Dana-Farber Cancer Institute
  • Yamuna Krishnan, University of Chicago
  • Chris am Ende, Pfizer
  • Mark Bunnage, Vertex
  • Niyi Fadeyi, Merck
  • Mary Matyskiela, BMS
  • Pat Walters, Relay

2018

Host: Novartis

  • Sara Buhrlage, Harvard University Dana-Farber Cancer Institute
  • Anne Carpenter, Broad Institute
  • Ben Cravatt, Scripps
  • Amanda Garner, University of Michigan
  • Jay Bradner, Novartis
  • Andy Phillips, C4 Therapeutics
  • Jennifer Petter, Arrakis Therapeutics
  • Ethan Perlstein, Perlara

2017

Host: AstraZenaca

  • Emily Balskus, Harvard University
  • Craig Crews, Yale University
  • Herbert Waldmann, Max Plank Institute
  • Eranthie Weerapana, Boston College
  • Doug Johnson, Pfizer
  • Phil Chamberlin, Neomorph
  • Alan Rigby, Warp Drive Bio
  • Paola Castaldi, AstraZeneca